-
Data Driven Site Selection for Clinical Trials in a Post-COVID-19 World
September 20, 2021 -
4 Effective Strategies to Accelerate Site Selection to Activation
September 14, 2021 -
Aggregate Reporting – Significance, Classification and Challenges
September 2, 2021 -
Literature Screening – Process overview, challenges en-route and the scope for automation
August 30, 2021 -
How Decentralized Clinical Trials Are Expected to Transform the Conduct of Global Clinical Studies
August 5, 2021 -
How the Trial Master File is Expected to Evolve in the Next Three Years
July 28, 2021 -
Emerging Trends in Regulatory Affairs by Adapting to Latest Technological Advancements
July 5, 2021 -
Automation Opportunities in Pharmacovigilance
June 25, 2021 -
Global Regulatory Changes in Biopharma
June 21, 2021
Princeton Office
- 101 College Road East Princeton NJ 08540 USA
- SBH Officers Colony, Mega Hills, Ayyappa Society, Madhapur
- (040) 4503 8660
- CLINICAL
- REGULATORY
- Regulatory Capabilities Overview
- Regulatory Affairs Services
- Regulatory Operations Services
- eCTD Publishing & Submission
- Regulatory Dossier Gap Analysis (IND,NDA,BLA,ANDA,CTA,MAA, DMF)
- Post-Approval Gap Analysis
- Product Registrations
- Artwork & Labeling
- SPL Conversions
- RLD updates & Labeling Services
- QRD Preparation-EMA
- SmPC & ePI
- Local Labeling & Translations
- Labeling Compliance & Advisory
- REMS & RMP Plans
- Life Cycle Management Services
- Specialized & Niche Services
- Content Authoring Services
- PHARMACOVIGILANCE
- PV Capabilities Overview
- PV Technology Solutions
- PV Oversight & Agentic AI
- PV Functional Services
- TOTALVigilance Services
- Case Processing Services
- Aggregate Safety Reports
- Literature Monitoring Services
- Safety Signal Management
- QPPV & LPPV Services
- PSMF Lifecycle Management
- PV Risk Management Services
- Med Info Contact Center
- Materiovigilance Services
- PV Audits & Training Services
- PV Regulatory Intelligence Services
- QUALITY & LABS
- MEDTECH
- CAPABILITIES
- ABOUT